From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
about
Immune System, Friend or Foe of Oncolytic Virotherapy?Potential of oncolytic viruses in the treatment of multiple myeloma.Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.Editorial of the Special Issue: Oncolytic Viruses as a Novel Form of Immunotherapy for Cancer.
P2860
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@en
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@nl
type
label
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@en
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@nl
prefLabel
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@en
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@nl
P2093
P2860
P1433
P1476
From Benchtop to Bedside: A Review of Oncolytic Virotherapy.
@en
P2093
Audrey H Choi
Michael P O'Leary
Nanhai G Chen
P2860
P356
10.3390/BIOMEDICINES4030018
P50
P577
2016-08-02T00:00:00Z